Educational Information

Target Audience

This activity has been designed to meet the educational needs of gastroenterologists and other healthcare providers involved in the care of patients with irritable bowel syndrome (IBS), chronic constipation (CC), and opioid-induced constipation (OIC).

Educational Objectives

After completing this activity, the participants should be better able to:

Describe randomized controlled trial data about the efficacy and safety of treatments of IBS and CC included in the American College of Gastroenterology Evidence-Based Position Statement on the Management of Irritable Bowel Syndrome and
Chronic Idiopathic Constipation

Describe randomized controlled trial data about the efficacy and safety of treatments of OIC

Formulate individualized treatment strategies based on the efficacy, safety and tolerability of available treatment as derived from published randomized controlled trial data

Identify treatments in development for IBS, CC,
and OIC